natgillin/translations-raw huggingface dataset:
Lyrica kan give svimmelhed, søvnighed og nedsat koncentrationsevne.
Lyrica may produce dizziness, sleepiness and decreased concentration.
Efter markedsføring har der været rapporter om overfølsomhedsreaktioner, herunder tilfælde af angioødem.
There have been reports in the postmarketing experience of hypersensitivity reactions, including cases of angioedema.
Efter markedsføring er der rapporteret om respirationssvigt, koma og dødsfald hos patienter, der tager pregabalin og opioider og/eller andre lægemidler, der supprimerer centralnervesystemet (CNS).
In the postmarketing experience, there are reports of respiratory failure, coma and deaths in patients taking pregabalin and opioids and/or other central nervous system (CNS) depressant medicinal products.
Denne øgede risiko blev set ved lave doser af pregabalin (≤ 300 mg, aOR 1,52 [95% CI, 1,04 til 2,22]) og der var en tendens til en større risiko ved høje doser pregabalin (> 300 mg, aOR 2,51 [95% CI 1,24 til 5,06]).
This increased risk was observed at low doses of pregabalin (≤ 300 mg, aOR 1.52 [95% CI, 1.04 - 2.22]) and there was a trend for a greater risk at high doses of pregabalin (> 300 mg, aOR 2.51 [95% CI 1.24 - 5.06]).
Perifere og centrale neuropatiske smerter: Lyrica anvendes til behandling af langvarige smerter, som skyldes beskadigede nervebaner.
Peripheral and central neuropathic pain: Lyrica is used to treat long lasting pain caused by damage to the nerves.
Hvis du ønsker yderligere oplysninger om Lyrica, skal du henvende dig til den lokale repræsentant for indehaveren af markedsføringstilladelsen:
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Pfizer Europe MA EEIG (som logo)
Pfizer Europe MA EEIG (as MA Holder logo)
Der tilrådes forsigtighed, når pregabalin ordineres samtidig med opioider, grundet risikoen for CNSdepression (se pkt.
Caution is advised when prescribing pregabalin concomitantly with opioids due to risk of CNS depression (see section 4.5).
Fremstiller: Pfizer Service Company, Hoge Wei 10, B 1930 Zaventem, Belgien.
Pfizer Service Company, Hoge Wei 10, B1930 Zaventem, Belgium
Lyrica påvirker i mindre eller moderat grad evnen til at føre motorkøretøj og betjene maskiner.
Lyrica may have minor or moderate influence on the ability to drive and use machines.
• Hos nogle patienter, der tager Lyrica, er der rapporteret om symptomer, der tyder på en overfølsomhedsreaktion.
• Some patients taking Lyrica have reported symptoms suggesting an allergic reaction.
HDPE-beholder, der indeholder 200 hårde kapsler.
HDPE bottle containing 200 hard capsules.
Perifere og centrale neuropatiske smerter, epilepsi eller generaliseret angst:
Peripheral and central neuropathic pain, epilepsy or Generalised Anxiety Disorder:
Lyrica kan forårsage svimmelhed og søvnighed, og derfor kan det påvirke evnen til at køre bil eller betjene maskiner.
Lyrica may cause dizziness and somnolence and therefore may influence the ability to drive or use machines.
Vend flasken med bunden i vejret (mens sprøjten sidder i) og fyld sprøjten med væske ved at trække stemplet tilbage til lige under den markering på sprøjten, der svarer til den mængde i milliliter (ml), som lægen har ordineret (figur 4).
Invert the bottle (with the syringe attached) and fill the syringe with the liquid by pulling the syringe plunger down to just beyond the graduation mark corresponding to the quantity in millilitres (ml) prescribed by your doctor (Figure 4).
• Lyrica er forbundet med svimmelhed og søvnighed, som kan øge risikoen for faldulykker hos ældre patienter.
• Lyrica has been associated with dizziness and somnolence, which could increase the occurrence of accidental injury (fall) in elderly patients.
Lyrica er indiceret som supplerende behandling til voksne med refraktære partielle anfald med eller uden sekundær generalisering.
Lyrica is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.
Engangsdosis * Total døgndosis (mg/døgn) skal fordeles som anført under dosisinterval for at give mg/dosis Supplerende dosis er en enkelt tillægsdosis.
BID = Two divided doses * Total daily dose (mg/day) should be divided as indicated by dose regimen to provide mg/dose Supplementary dose is a single additional dose
Pfizer Manufacturing Deutschland GmbH, Betriebsstātte Freiburg, Mooswaldallee 1, 79090 Freiburg, Tyskland.
Pfizer Manufacturing Deutschland GmbH, Betriebsstātte Freiburg, Mooswaldallee 1, 79090 Freiburg, Germany.
Farmakoterapeutisk klassifikation: Antiepileptika, andre antiepileptika, ATC-kode: N03AX16
5.1 Pharmacodynamic properties Pharmacotherapeutic group: Anti-epileptics, other anti-epileptics ATC code: N03AX16
Administrationsmetode
Method of Administration
Må ikke anvendes, hvis forseglingen er brudt.
Sealed Pack Do not use if box has been opened.
Lyrica 20 mg/ml er en klar, farveløs opløsning i en hvid flaske, der indeholder 473 ml oral opløsning.
Lyrica 20 mg/ml oral solution is a clear colourless solution in a white bottle containing 473 ml of oral solution, in a cardboard carton.
Lyrica dosis (mg)
Lyrica Dose (mg)
• Lyrica kan forårsage sløret syn, synstab eller andre synsændringer, som kan være forbigående.
• Lyrica may cause blurring or loss of vision, or other changes in eyesight, many of which are temporary.
Pregabalin 14 mg/kg/dag reducerede væsentligt den log-transformerede hyppighed af partielle anfald versus placebo (p=0,0223); pregabalin 7 mg/kg/dag viste ingen forbedring i forhold til placebo.
Pregabalin 14 mg/kg/day significantly reduced the log-transformed partial onset seizure frequency versus placebo (p=0.0223); pregabalin 7 mg/kg/day did not show improvement relative to placebo.
• Der er set kramper i forbindelse med behandling med Lyrica og kort tid efter ophør af behandling med Lyrica.
• There have been reports of convulsions when taking Lyrica or shortly after stopping Lyrica.
Først fyldes sprøjten med 5 ml, og indholdet indtages direkte gennem munden, derefter fyldes sprøjten med 2,5 ml, og indholdet indtages gennem munden).
Using the oral syringe, first withdraw 5 ml and empty contents of syringe directly into the mouth, then refill the oral syringe with 2.5 ml and empty the remaining contents into the mouth.]
Lyrica bør ikke tages under graviditet, eller mens du ammer medmindre din læge har givet dig en anden besked.
Lyrica should not be taken during pregnancy or when breast-feeding, unless you are told otherwise by your doctor.
De er anført efter organklasse og hyppighed (meget almindelig (≥ 1/10); almindelig (≥ 1/100 til < 1/10); ikke almindelig (≥ 1/1.000 til < 1/100); sjælden (≥ 1/10.000 til < 1/1.000); meget sjældne (< 1/10.000)), hyppighed ikke kendt (kan ikke estimeres ud fra forhåndenværende data).
In table 2 below all adverse reactions, which occurred at an incidence greater than placebo and in more than one patient, are listed by class and frequency (very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data).
In vivo studier og populations farmakokinetiske analyser Følgelig har in vivo studier ikke vist klinisk relevante farmakokinetiske interaktioner mellem pregabalin og phenytoin, carbamazepin, valproat, lamotrigin, gabapentin, lorazepam, oxycodon eller ethanol.
In vivo studies and population pharmacokinetic analysis Accordingly, in in vivo studies no clinically relevant pharmacokinetic interactions were observed between pregabalin and phenytoin, carbamazepine, valproic acid, lamotrigine, gabapentin, lorazepam, oxycodone or ethanol.
Efter markedsføring er der rapporteret om bivirkninger relateret til nedsat funktion af mave-tarmkanalen (f.eks intestinal obstruktion, paralytisk ileus, obstipation), når pregabalin gives samtidig med lægemidler, der potentielt kan medføre obstipation, herunder opioide analgetika.
There are postmarketing reports of events related to reduced lower gastrointestinal tract function (e.g. intestinal obstruction, paralytic ileus, constipation) when pregabalin was co-administered with medications that have the potential to produce constipation, such as opioid analgesics.
Kapslen er mærket med et sort bånd på underdelen af kapslen.
The capsule body is marked with a black band.
Neuropatiske smerter Lyrica er indiceret til behandling af perifere og centrale neuropatiske smerter hos voksne.
Neuropathic pain Lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults.
100 × 1 hårde kapsler i PVC/aluminium perforeret enkeltdosisblister.
100 x 1 hard capsules in PVC/Aluminium perforated unit dose blisters.
Du må ikke stoppe med at tage Lyrica, medmindre din læge har bedt dig herom.
Do not stop taking Lyrica unless your doctor tells you to.
Kontakt lægen eller apotekspersonalet, før du tager Lyrica
Warnings and Precautions Talk to your doctor or pharmacist before taking Lyrica.
Efter markedsføring er der set tilfælde af øjenbivirkninger, herunder synstab, sløring af synet eller andre forandringer i synsskarpheden, hvoraf mange var forbigående.
In the postmarketing experience, visual adverse reactions have also been reported, including loss of vision, visual blurring or other changes of visual acuity, many of which were transient.
Det aktive indholdsstof, pregabalin, er en gamma-aminosmørsyre analog [(S)-3-(aminomethyl)-5methylhexansyre].
The active substance, pregabalin, is a gamma-aminobutyric acid analogue [(S)-3-(aminomethyl)-5-methylhexanoic acid].
Lyrica indeholder
What Lyrica contains
Hjælpestoffer, der kan give overfølsomhedsreaktioner
Excipients which may cause allergic reactions
Hvis du holder op med at tage Lyrica
If you stop taking Lyrica
Epilepsi: Lyrica anvendes til behandling af visse former for epilepsi (partielle anfald med eller uden sekundær generalisering - epileptiske anfald der starter i en bestemt del af hjernen) hos voksne.
Epilepsy: Lyrica is used to treat a certain form of epilepsy (partial seizures with or without secondary generalisation-epileptic fits starting on one specific part of the brain) in adults.
Pregabalin er undersøgt i 6 kontrollerede studier af 4-6 ugers varighed, et studie med ældre af 8 ugers varighed og et langtids relaps-forebyggelsesstudie med en dobbelt-blind relaps-forebyggelsesfase af 6 måneders varighed.
Pregabalin has been studied in 6 controlled trials of 4-6 week duration, an elderly study of 8 week duration and a long-term relapse prevention study with a double-blind relapse prevention phase of 6 months duration.
Når du stopper med at tage Lyrica efter langtidsbehandling eller korttidsbehandling, skal du vide, at du måske får visse bivirkninger.
After stopping long and short-term Lyrica treatment, you need to know that you may experience certain side effects.
Hvis du har glemt at tage Lyrica
If you forget to take Lyrica
• Tag opløsningen, som lægen har ordineret.
• Take the solution as instructed by your doctor.
Total opløsning volume (ml)
Total Solution Volume (ml)
Optrækning med oral sprøjte af ordineret dosis af Lyrica
Oral Syringe Withdrawals to Deliver Prescribed Dose of Lyrica
473 ml oral opløsning med en 5 ml oral sprøjte og en tryk-i-flaskeadptor (PIBA).
473 ml oral solution with a 5 ml oral syringe and a Press-In Bottle Adapter (PIBA).
Tøm indholdet af sprøjten i munden (figur 7).
Discharge the syringe contents into the mouth (Figure 7).
Derudover findes Lyrica i en HDPE-beholder, der indeholder 200 kapsler for 25 mg, 75 mg, 150 mg og 300 mg styrken.
In addition, Lyrica is available in an HDPE bottle containing 200 capsules for the 25 mg, 75 mg, 150 mg and 300 mg strengths.
Karton
CARTON
Brug af anden medicin sammen med Lyrica
Other medicines and Lyrica
Hårde kapsler.
Hard capsules
En pakning med 14 kapsler i 1 blisterplade, 21 kapsler i 1 blisterplade, 56 kapsler i 4 blisterplader, 70 kapsler i 5 blisterplader, 84 kapsler i 4 blisterplader, 100 kapsler i 10 blisterplader, 112 kapsler i 8 blisterplader og 100 × 1 kapsel som perforeret enkeltdosisblister.
Lyrica is available in eight pack sizes made of PVC with an aluminium foil backing: a 14 capsules pack containing 1 blister strip, a 21 capsules pack containing 1 blister strip, a 56 capsules pack containing 4 blister strips, a 70 capsules pack containing 5 blister strips, a 84 capsules pack containing 4 blister strips, a 100 capsules pack containing 10 blister strips, a 112 capsules pack containing 8 blister strips and 100 x 1 capsules as perforated unit dose blisters.
Fjern luftboblerne fra sprøjten ved at skubbe stemplet tilbage i sprøjten til den relevante markering på sprøjten.
Remove air bubbles from the syringe by pushing the plunger up to the appropriate graduation mark.
Lyrica kan tages sammen med svangerskabsforebyggende medicin.
Lyrica may be taken with oral contraceptives.
Den mest almindelige bivirkning, der blev observeret i studiet af 12 ugers varighed med behandling med pregabalin, var døsighed, pyreksi, øvre luftvejsinfektioner, øget appetit, vægtøgning og nasopharyngitis.
The most common adverse events observed in the 12-week study with pregabalin treatment were somnolence, pyrexia, upper respiratory tract infection, increased appetite, weight increased, and nasopharyngitis.
Efter markedsføring er der rapporteret om hjerteinsufficiens hos nogle patienter i behandling med pregabalin.
There have been postmarketing reports of congestive heart failure in some patients receiving pregabalin.
Efter yderligere 7 dage kan dosis øges til 450 mg (22,5 ml) dagligt.
Following an additional week the dose may be increased to 450 mg (22.5 ml) per day.
Rens sprøjten og sæt låget på flasken (PIBA bliver siddende) (figur 8 og 9).
Rinse the syringe and replace the cap on the bottle (PIBA remains in place) (Figures 8 and 9).
Du kan føle dig søvnig, forvirret, oprevet eller rastløs, hvis du har taget for mange Lyrica.
You may feel sleepy, confused, agitated, or restless as a result of taking more Lyrica than you should.
Lyrica kan tages med eller uden mad.
Lyrica may be taken with or without food.
Det skal du vide, før du begynder at tage Lyrica
What you need to know before you take Lyrica
Den sikkerhedsprofil for pregabalin, der blev observeret i 4 pædiatriske studier hos patienter med partielle anfald med eller uden sekundær generalisering (effekt- og sikkerhedsstudie af 12 ugers varighed hos patienter i alderen 4-16 år, n=295; effekt- og sikkerhedsstudie af 14 dages varighed hos patienter i alderen fra 1 måned til under 4 år, n=175; farmakokinetik- og tolerabilitetsstudier, n=65; og 1 års åben opfølgning af sikkerhedsstudiet, n=54), var den samme som den, der blev observeret i studier med voksne patienter med epilepsi.
The pregabalin safety profile observed in four paediatric studies in patients with partial seizures with or without secondary generalisation (12-week efficacy and safety study in patients 4 to 16 years of age, n=295; 14-day efficacy and safety study in patients 1 month to younger than 4 years of age, n=175; pharmacokinetic and tolerability study, n=65; and 1 year open label follow on safety study, n=54) was similar to that observed in the adult studies of patients with epilepsy.
Lyrica tilhører den gruppe medicin, der anvendes til behandling af epilepsi, neuropatiske smerter og generaliseret angst hos voksne.
Lyrica belongs to a group of medicines used to treat epilepsy, neuropathic pain and Generalised Anxiety Disorder (GAD) in adults.
Brug ikke lægemidlet efter den udløbsdato, der står på pakningen efter EXP. Udløbsdatoen er den sidste dag i den nævnte måned.
Do not use this medicine after the expiry date which is stated on the carton or bottle.
Epilepsi: Lyrica anvendes til behandling af visse former for epilepsi (partielle anfald med eller uden sekundær generalisering) hos voksne.
Epilepsy: Lyrica is used to treat a certain form of epilepsy (partial seizures with or without secondary generalisation) in adults.
• 75 mg, 100 mg, 200 mg, 225 mg og 300 mg kapsler indeholder også rød jernoxid (E172).
The 75 mg, 100 mg, 200 mg, 225 mg and 300 mg capsules also contain red iron oxide (E172).
Tryk sprøjtens stempel i bund (mod spidsen) for at fjerne overskydende luft.
Push the syringe plunger to the bottom of the barrel of the syringe (toward its tip) to remove excess air.
Lyrica oral opløsning indeholder methylparahydroxybenzoat og propylparahydroxybenzoat, som kan give overfølsomhedsreaktioner (muligvis forsinkede).
Lyrica oral solution contains methyl parahydroxybenzoate and propyl parahydroxybenzoate which may cause allergic reactions (possibly delayed).
Virkning og anvendelse Det skal du vide, før du begynder at tage Lyrica Sådan skal du tage Lyrica Bivirkninger
What Lyrica is and what it is used for What you need to know before you take Lyrica How to take Lyrica
Øvrige hjælpestoffer inkluderer E216 (propylparahydroxybenzoat) og E218 (methylparahydroxybenzoat).
Other ingredients include E216 (propyl parahydroxybenzoate) and E218 (methyl parahydroxybenzoate).
For 3 gange dagligt skal Lyrica tages én gang om morgenen, én gang om eftermiddagen og én gang om aftenen, og på omtrent samme tid hver dag.
For three times a day take Lyrica once in the morning, once in the afternoon and once in the evening, at about the same time each day.
Tilpasningsproppen sættes i flaskehalsen for at gøre det nemmere at trække opløsningen ind i sprøjten.
This is the device that gets inserted into the neck of the bottle to make it easier to withdraw the solution using the oral syringe.
• Øvrige indholdsstoffer: Lactosemonohydrat, majsstivelse, talcum, gelatine, titandioxid (E171), natriumlaurilsulfat, vandfri kolloid silica, sort blæk, (som indeholder shellac, sort jernoxid (E172), propylenglycol, kaliumhydroxid) og renset vand.
The other ingredients are: lactose monohydrate, maize starch, talc, gelatine, titanium dioxide (E171), sodium laurilsulphate, anhydrous colloidal silica, black ink, (which contains shellac, black iron oxide (E172), propylene glycol, potassium hydroxide) and water.
En karton indeholder en hvid højdensitetspolyethylen (HDPE) flaske med et polyethylen-foret låg med 473 ml oral opløsning.
A white high density polyethylene (HDPE) bottle with polyethylene-lined closure, containing 473 ml of oral solution, in a cardboard carton.
Når det bruges sammen med visse typer medicin, som har beroligende virkninger (herunder opioider), kan Lyrica forstærke disse virkninger, og kan føre til åndedrætssvigt, dyb bevidstløshed og død.
When taken with certain other medicines which have sedative effects (including opioids), Lyrica may potentiate these effects, and could lead to respiratory failure, coma and death.
Den maksimale dosis på 600 mg (30 ml) dagligt kan nås efter yderligere 7 dage.
The maximum dose of 600 mg (30 ml) per day may be achieved after an additional week.
Medbring pakningen med Lyrica kapsler.
Take your box or bottle of Lyrica capsules with you.
Resultaterne af et placebokontrolleret studie af 12 ugers varighed med 295 pædiatriske patienter i alderen 4-16 år og et placebokontrolleret studie af 14 dages varighed med 175 pædiatriske patienter i alderen fra 1 måned til under 4 år, som blev udført for at vurdere effekt og sikkerhed af pregabalin som tillægsbehandling ved behandling af partielle anfald og et åbent sikkerhedsstudie af 1 års varighed med 54 pædiatriske epilepsipatienter i alderen fra 3 måneder til 16 år indikerer, at bivirkningerne pyreksi og øvre luftvejsinfektioner blev observeret hyppigere end i studier med voksne epilepsipatienter (se pkt.
Results of a 12-week placebo-controlled study of 295 paediatric patients aged 4 to 16 years and a 14-day placebo-controlled study of 175 paediatric patients aged 1 month to younger than 4 years of age performed to evaluate the efficacy and safety of pregabalin as adjunctive therapy for the treatment of partial onset seizures and a 1 year open label safety study in 54 paediatric patients from 3 months to 16 years of age with epilepsy indicate that the adverse events of pyrexia and upper respiratory infections were observed more frequently than in adult studies of patients with epilepsy (see sections 4.2, 4.8 and 5.2).
Behandling af centrale neuropatiske smerter, der skyldes rygmarvsskader Ved behandling af centrale neuropatiske smerter, der skyldes rygmarvsskader, ses generelt en øget forekomst af bivirkninger, bivirkninger i centralnervesystemet og især søvnighed.
Treatment of central neuropathic pain due to spinal cord injury In the treatment of central neuropathic pain due to spinal cord injury the incidence of adverse reactions in general, central nervous system adverse reactions and especially somnolence was increased.
1 hård kapsel indeholder 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg eller 300 mg pregabalin.
Each hard capsule contains either 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg or 300 mg pregabalin.
• Når Lyrica tages med andre lægemidler, som er kendt for at kunne give forstoppelse (som f.eks visse typer smertestillende medicin), kan det give maveproblemer (f.eks. forstoppelse, tarmslyng).
• When Lyrica is taken with other medicines that may cause constipation (such as some types of pain medicines) it is possible that gastrointestinal problems may occur (e.g. constipation, blocked or paralysed bowel).
• hvis du er allergisk over for pregabalin eller et af de øvrige indholdsstoffer (angivet i punkt 6).
Do not take Lyrica: If you are allergic to pregabalin or any of the other ingredients of this medicine (listed in section 6).
• Den dosis, som er blevet tilpasset til dig og din tilstand, vil normalt være mellem 150 mg (7,5
• The dose, which has been adjusted for you and your condition, will generally be between 150 mg (7.5 ml) and 600 mg (30 ml) each day.
Øvrige indholdsstoffer: methylparahydroxybenzoat (E218), propylparahydroxybenzoat (E216), vandfri natriumdihydrogenphosphat, vandfri dinatriumphosphat (E339), sucralose (E955), kunstig jordbærsmag (indeholder små mængder ethanol (alkohol)), renset vand.
The other ingredients are: methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), sodium dihydrogen phosphate, anhydrous, disodium phosphate, anhydrous (E339), sucralose (E955), artificial strawberry flavour (contains small amounts of ethanol (alcohol), purified water.
kvinder)
patients)
Kartonen indeholder også en gennemsigtig polyethylen-indpakning med en 5 ml gradueret oral sprøjte og en tryk-i-flaskeadaptor (PIBA).
The carton also contains, in a clear polyethylene wrap, a 5 ml graduated oral syringe and a Press-In Bottle adapter (PIBA).
Vend flasken om i opret stilling og tag den fyldte sprøjte ud (figur 5 og 6).
Remove the filled syringe from the bottle in the upright position (Figures 5 and 6).
Rens sprøjten ved at trække vand ind i sprøjten og trykke stemplet i bund mindst 3 gange (figur
Rinse the syringe by drawing water into the syringe and pushing the syringe plunger to the bottom of the syringe barrel, at least three times (Figure 8).
• Nogle diabetespatienter kan få vægtøgning, når de tager Lyrica, og kan derfor have behov for at ændre deres diabetesmedicin.
• Some patients with diabetes who gain weight while taking pregabalin may need an alteration in their diabetic medicines.
Lyrica indeholder lactosemonohydrat
Lyrica contains lactose monohydrate
For 2 gange dagligt skal Lyrica tages én gang om morgenen og én gang om aftenen, og på omtrent samme tid hver dag.
For twice a day take Lyrica once in the morning and once in the evening, at about the same time each day.
Generaliseret angst Lyrica er indiceret til behandling af generaliseret angst (GAD) hos voksne.
Generalised Anxiety Disorder Lyrica is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.
Tøm indholdet af sprøjten direkte ind i munden ved at trykke sprøjtens stempel i bund (figur 7).
Empty the contents of the syringe directly into mouth by pushing the syringe plunger to the bottom of the syringe barrel (Figure 7).
Åben flasken: Tryk låget nedad samtidig med at det drejes mod uret (figur 1).
Open the bottle: Press downward on the cap and turn it counter-clockwise (Figure 1).
Lyrica 75 mg, 100 mg, 200 mg, 225 mg, 300 mg hårde kapsler
Lyrica 75 mg, 100 mg, 200 mg, 225 mg, 300 mg hard capsules
Pfizer Luxembourg SARL filialas Lietuvoje nia Tel. +3705 2514000
Pfizer Luxembourg SARL filialas Lietuvoje Tel. +3705 2514000